<PAGE> 1
U. S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
FORM 10-Q (AMENDMENT NO. 1)*
(Mark one)
/X/ Quarterly report pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934 for the quarterly period ended September 28, 1996 or
/ / Transition report pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934 for the transition period from _________ to _________
COMMISSION FILE NUMBER: 1-8145
THORATEC LABORATORIES CORPORATION
(Exact Name of Small Business Issuer as Specified in Its Charter)
<TABLE>
<CAPTION>
California 94-2340464
<S> <C>
(State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.)
2023 Eighth Street, Berkeley, California 94710
(Address of Principal Executive Offices) (Zip Code)
</TABLE>
Registrant's telephone number, including area code: (510) 841-1213
Indicate by check mark whether the registrant: (1) has filed
all reports required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such shorter period
that the registrant was required to file such reports), and (2) has been subject
to such filing requirements for the past 90 days. Yes X No
--- ---
As of November 4, 1996, registrant had 17,928,861 shares of
common stock outstanding.
*Amended to include Exhibit 27 -- Financial Data Schedule.
<PAGE> 2
SIGNATURES
In accordance with the requirements of the Exchange Act, the registrant caused
this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
THORATEC LABORATORIES CORPORATION
Date: November 6, 1996 /s/ D. Keith Grossman
----------------- -------------------------------------------
D. Keith Grossman, Chief Executive Officer
Date: November 6, 1996 /s/ Cheryl D. Hess
----------------- -------------------------------------------
Cheryl D. Hess, Chief Financial Officer
- 13 -
<PAGE> 3
EXHIBIT INDEX
Exhibit Number Document
11 Statement Re: Computation of Per-Share Earnings
27 Financial Data Schedule
- 14 -
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONDENSED CONSOLIDATED BALANCE SHEETS AND THE CONDENSED CONSOLIDATED STATEMENTS
OF OPERATIONS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH QUARTERLY
REPORT (FORM 10-Q) PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND
EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 28, 1996.
</LEGEND>
<MULTIPLIER> 1
<CURRENCY> U.S. DOLLARS
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-28-1996
<PERIOD-START> DEC-31-1995
<PERIOD-END> SEP-28-1996
<EXCHANGE-RATE> 1
<CASH> 6,152,352
<SECURITIES> 10,946,287
<RECEIVABLES> 1,190,903
<ALLOWANCES> 0
<INVENTORY> 2,334,129
<CURRENT-ASSETS> 20,857,724
<PP&E> 2,360,980
<DEPRECIATION> 1,810,269
<TOTAL-ASSETS> 22,331,248
<CURRENT-LIABILITIES> 2,014,285
<BONDS> 0
0
0
<COMMON> 63,519,027
<OTHER-SE> (43,202,064)
<TOTAL-LIABILITY-AND-EQUITY> 22,331,248
<SALES> 5,491,356
<TOTAL-REVENUES> 5,821,095
<CGS> 2,387,049
<TOTAL-COSTS> 2,387,049
<OTHER-EXPENSES> 5,561,670
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 45,811
<INCOME-PRETAX> (2,173,435)
<INCOME-TAX> 0
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (2,173,435)
<EPS-PRIMARY> (.13)
<EPS-DILUTED> (.13)
</TABLE>
